Usefulness of PCNA labeling index and p53 expression in determining prognosis in osteosarcoma
β Scribed by Hideo Shiraishi; Toshiyuki Kotake
- Publisher
- Springer Japan
- Year
- 1997
- Tongue
- English
- Weight
- 914 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0949-2658
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In a series of 71 patients with advanced colorectal cancer treated with biochemically modulated 5-fluorouracil(5-FU) and methotrexate (MTX), we investigated the relationship between the proliferating-cell nuclear antigen (PCNA) (PC 10) and p53 (Pab I80 I) primary-tumor immunohistochemical expression
Background. The aim of this study was to compare the clinical features and proliferating cell nuclear antigen (PCNA), p53, Bcl-X, and Bax expression in primary oral basaloid squamous cell carcinoma (BSCC) and poorly differentiated squamous cell carcinoma (PDSCC) matched by stage and site and to asse